Fluoroquinolone resistance in Escherichia coli and Klebsiella pneumoniae over 18 years: Effect of different systems for eliminating duplicates

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 9, 2011, Pages 2182-2184

  Noguera, Obdulia ^a   LÓpez Riquelme, Natividad ^b   Rodríguez, Juan Carlos ^b   Belda, Sofía ^b   Galiana, Antonio ^b   Ruiz García, Montserrat ^b   López García, Pilar ^b   Royo, Gloria ^b,c  

^a HOSPITAL VEGA BAJA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Antimicrobial resistance; Antimicrobial susceptibility; Ciprofloxacin; E. coli; Epidemiology; Extended spectrum lactamases; K. pneumoniae

Indexed keywords

CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BROTH DILUTION; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; LETTER; NONHUMAN;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS;

EID: 80051692731     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr241     Document Type: Letter

References (10)

1. Rodríguez JC, Sirvent E, LÓpez-Lozano JM et al. Criteria of time and antibiotic susceptibility in the elimination of duplicates when calculating resistance frequencies. J Antimicrob Chemother 2003; 52: 132-4.
2. Cebrián L, Rodríguez JC, Escribano I et al. Influence of various criteria for elimination of duplicates when calculating the prevalence and antibiotic susceptibility of microorganisms associated with urinary infections. Int J Antimicrob Agents 2005; 25: 173-6.
3. National Committee for Clinical Laboratory Standards. Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data: Approved Guideline M39-A. NCCLS, Wayne, PA, USA, 2002.
4. Cornaglia G, Hryniewicz W, Jarlier V et al. European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect 2004; 10: 349-83.
5. Angel Díaz M, Ramón Hernández J, Martínez-Martínez L et al. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006). Enferm Infecc Microbiol Clin 2009; 27: 503-10.
6. Kang CI, Kim SH, Kim DM et al. Risk factors for ciprofloxacin resistance in bloodstream infections due to extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Microb Drug Resist 2004; 10: 71-6.
7. Erb A, Sturmer T, Marre R et al. Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis 2007; 26: 83-90.
8. Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother 2008; 62: 1-9.
9. Sundqvist M, Kahlmeter G. Effect of excluding duplicate isolates of Escherichia coli and Staphylococcus aureus in a 14 year consecutive database. J Antimicrob Chemother 2007; 59: 913-8.
10. Ortega M, Marco F, Soriano A et al. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother 2009; 63: 568-74.